Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer
Clinical trial NCT06858969 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06858969
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-09
- Primary completion
- 2026-01-08
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.